Two studies mapped the structures of VPS13 proteins associated with neurodegenerative diseases, laying the groundwork for understanding how mutations disrupt cellular lipid transport.

GLP-1 drugs may influence cancer risk by reversing obesity-related metabolic dysfunction and inflammation. Researchers are ...

Data silos in bioprocessing limit quality, compliance, and operational efficiency. Cloud-based LIMS–MES integration can create a single source of data, enabling better traceability, faster batch ...

Researchers developed a modified DNA platform designed to reduce innate immune activation while maintaining gene expression. The approach could provide durable, redosable genetic therapies without the ...

SLIM technology can drastically increase the available flight path for ion mobility separation, revealing previously hidden data. Hear from experts at MOBILion Systems on how this technology could ...

Technology Networks spoke with PacBio's Amit Patel and Covaris' Greg Endress about how integrated extraction, library preparation, and HiFi sequencing workflows are unlocking new opportunities for ...

Explore the latest metabolomics advances, from 4D analysis to hybrid workflows and dual ionization techniques that provide confident identification, reliable quantitation, and actionable results.

Edwin Hauw and Tilmann Burckstummer discuss how automation and multimodal analysis are addressing long-standing limitations of optical pooled screening, enabling more scalable and informative CRISPR ...

Air exposomics combines environmental science and health life science research to uncover how airborne contaminants affect human wellbeing and disease risk. Discover how advanced mass spectrometry is ...

As cell therapies move into broader disease areas, developers face increasing pressure to demonstrate manufacturing readiness. John Tomtishen discusses why CMC considerations are shifting from a ...

Restoration of BMP3 protein reversed pulmonary vascular remodeling and improved cardiac function in preclinical models of pulmonary arterial hypertension. Results were consistent across gene therapy ...

New research identified a previously unknown type of brain plaque that may emerge at the earliest stages of Alzheimer's disease. The mitochondrial plaques offer a new potential therapeutic target.